ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Roche CDR

Roche CDR (ROG)

25,63
-0,19
(-0,74%)
Geschlossen 07 Juni 10:12PM

Roche CDR (ROG) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
25,63
( -0,74% )
Gebot
25,49
Fragen
25,80
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
25,82
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
$ 1.029.896
Ausgegebene Aktien
795.617.637
Dividendenrendite (LTM)
9,8 (3,11%)
Kurs-Gewinn-Verhältnis
20,53
Gewinn pro Aktie (EPS)
16,04
Erlöse (LTM)
63,36B
Nettogewinn (LTM)
12,88B

Über Roche CDR

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases... Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland. Mehr anzeigen

Sektor
-
Branche
-
Website
Hauptsitz
Basel, Switzerland
Gegründet
1896
Roche CDR is listed in the sector of the Toronto Börse with ticker ROG. The last closing price for Roche CDR was $25,82. Over the last year, Roche CDR shares have traded in a share price range of $ 0,00 to $ 0,00.

Roche CDR currently has 795.617.637 shares in issue. The market capitalisation of Roche CDR is $20,39 billion. Roche CDR has a price to earnings ratio (PE ratio) of 20.53.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

ROG - Frequently Asked Questions (FAQ)

What is the current Roche CDR share price?
The current share price of Roche CDR is $ 25,63
How many Roche CDR shares are in issue?
Roche CDR has 795.617.637 shares in issue
What is the market cap of Roche CDR?
The market capitalisation of Roche CDR is CAD 20,39B
What is the 1 year trading range for Roche CDR share price?
Roche CDR has traded in the range of $ 0,00 to $ 0,00 during the past year
What is the PE ratio of Roche CDR?
The price to earnings ratio of Roche CDR is 20,53
What is the cash to sales ratio of Roche CDR?
The cash to sales ratio of Roche CDR is 4,15
What is the registered address of Roche CDR?
The registered address for Roche CDR is Grenzacherstrasse 124, Basel, Basel-Stadt, 4070
What is the Roche CDR website address?
The website address for Roche CDR is www.roche.com

ROG Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen